top of page
ImmunoCare logo

Advancing brain tumor treatment with MRI-guided laser ablation: a new era in precision neuro-oncology

  • Writer: ImmunoCare
    ImmunoCare
  • May 21
  • 4 min read

Updated: Aug 27

Treating brain tumors remains one of the most complex challenges in modern medicine. Between the sensitivity of brain tissue and the protective blood-brain barrier, standard treatments like surgery, radiation, or chemotherapy can pose significant risks or lead to recurrence. At ImmunoCare, we continually explore and monitor the most advanced therapies available, ensuring our patients have access to the latest and most promising options in neuro-oncology.


One such innovation is the use of Visualase™ MRI-Guided Laser Ablation, especially when enhanced with Gold Nanostars (GNS), a technique showing promising results in targeted, minimally invasive tumor treatment.



Understanding brain tumors and their treatment challenges


Brain tumors are notoriously difficult to treat due to their location and the sensitivity of surrounding tissue. Traditional treatments like surgical resection or radiation often come with high risks and don’t always prevent recurrence. That’s why researchers have been exploring alternatives such as Laser Interstitial Thermal Therapy (LITT), a technique that applies focused heat to destroy tumor tissue with minimal damage to surrounding healthy brain structures.


Brain tumor research with ImmunoCare
Understanding brain tumor

What is Visualase™?


Visualase™ is a cutting-edge MRI-guided laser ablation system designed to target and treat intracranial tumors, epilepsy, and other brain-related conditions with high precision.


  • MRI guidance ensures real-time imaging and temperature monitoring

  • Thermal ablation targets the tumor directly with controlled laser energy

  • Used for a variety of tumors and neurological conditions, including:

    • Brain tumors

    • Epilepsy

    • Radio-necrosis

    • Potential treatment of peripheral nerve tumors


This approach combines real-time imaging with focused laser technology, offering a safe and precise alternative to traditional neurosurgery.


Visualase™ brain tumor
Visualase™

How does Visualase™ work?


The system uses a diode laser inserted through a minimally invasive probe. Real-time MRI scans guide the laser’s exact positioning and allow clinicians to monitor thermal energy in real time. This ensures the tumor is effectively ablated without harming nearby healthy brain tissue.


  • Thermal monitoring allows for precise energy control

  • Damage thresholds are pre-set to avoid unintended injury

  • The technique supports post-op assessment through imaging


This real-time precision is a breakthrough in neurosurgical safety, especially for tumors located in delicate or hard-to-reach brain regions.


thermal monitoring and diode laser for brain tumor


Enhancing laser therapy with Gold Nanostars


To push the boundaries of precision even further, researchers have explored ways to enhance LITT using Gold Nanostars (GNS), microscopic particles designed to amplify the thermal effects of laser ablation.


How it works:

Gold Nanostars accumulate in tumor tissues and act like “lightning rods,” intensifying the heat produced by the laser. This allows for:


  • More effective tumor ablation at lower power levels

  • Improved precision, targeting only the tumor while preserving healthy tissue

  • Reduced treatment risks for complex or inoperable cases


The ability to fine-tune heat distribution using GNS adds a powerful layer of control and safety to the treatment.


gold nanostars for brain tumor
Gold Nanostars

Clinical results and implications


Preclinical studies using mouse models have demonstrated highly promising outcomes with GNS-enhanced LITT:


  • Mice treated with GNS + LITT showed significantly improved survival rates

  • The thermal effects were more concentrated in tumor areas, reducing collateral damage

  • Heat distribution was more uniform, ensuring consistent ablation



These results suggest that combining GNS with Visualase™ could become a preferred option for patients with tumors that are difficult to access surgically or have recurred after prior treatments.



Safety and considerations


As with any medical procedure, safety is a primary concern. The Visualase™ system includes built-in safety protocols and monitoring tools to protect patients:


🚫 Contraindications:


  • Not recommended for patients intolerant to anesthesia

  • Caution in cases where laser therapy may not be effective (e.g., deep or scarred tissue)


⚠️ Important safety instructions:


  • Must be used in dry, electrically grounded environments

  • Only trained professionals should operate the system

  • Thermal thresholds are monitored in real time to protect healthy tissue


Being aware of potential adverse events, like neurological changes, intracranial bleeding, or edema, is essential for both patients and providers. This is why close monitoring is performed during and after treatment.


Looking ahead: future directions


The future of brain tumor treatment is being shaped by ongoing research into GNS-enhanced LITT. Areas of continued development include:


  • Optimizing GNS size, dosage, and concentration

  • Fine-tuning laser settings and treatment protocols

  • Conducting clinical trials to validate safety and efficacy in human patients

  • Establishing standardized protocols for regulatory approval



Conclusion


The integration of Visualase™ MRI-Guided Laser Ablation with Gold Nanostars (GNS) marks a significant leap forward in the treatment of brain tumors. This innovation offers a compelling blend of precision, safety, and minimally invasive care, addressing one of the most complex and delicate challenges in modern oncology. By enhancing thermal targeting at the cellular level, GNS technology allows for lower power settings and reduced damage to surrounding healthy brain tissue, making it particularly suitable for difficult-to-reach or recurrent tumors.


But for patients, innovation alone is not enough.


Navigating a brain tumor diagnosis is an emotional and overwhelming journey. Questions often outnumber answers. Treatment paths are complex, time-sensitive, and geographically scattered. That’s where ImmunoCare steps in, not as a provider of treatments, but as a trusted medical consultancy offering clarity, guidance, and connection to leading-edge solutions like Visualase™.


At ImmunoCare, we help patients and caregivers explore their options with confidence. Whether you’re seeking a second opinion, trying to understand which treatments might be suitable, or looking to access specialized clinics and trials, our role is to support you at every step:


  • We translate complex science into clear choices

  • We connect you with international experts in brain oncology

  • We prioritize your values, preferences, and well-being, not just the diagnosis



In a rapidly evolving medical landscape, access to the right information, and the right team, can make all the difference. Our work goes beyond technology: it’s about empowering patients with timely, personalized medical insight that can open doors to new possibilities.


If you or a loved one is navigating a brain tumor diagnosis and want to better understand your treatment landscape, reach out to our team at ImmunoCare. We’re here to help you make informed decisions, guided by both science and compassion.




 
 
 
bottom of page